C. David James, Ph.D.
Affiliations: | Neurological Surgery | University of California, San Francisco, San Francisco, CA |
Area:
EGF receptor, PTEN, EAG2, BRAFV600E kinase, CDKN2AWebsite:
http://neurosurgery.ucsf.edu/index.php/research_btrc_james.htmlGoogle:
"C. David James"Mean distance: 35622
Collaborators
Sign in to add collaborator| National Brain Tumor Society | collaborator | National Brain Tumor Society |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kumthekar P, Ko CH, Paunesku T, et al. (2021) A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma. Science Translational Medicine. 13 |
| Zhang DY, Dmello C, Chen L, et al. (2019) Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| XI G, Mahenthiran A, Best B, et al. (2019) EXTH-18. PEPTIDE NANO-STRUCTURES ENHANCE PEDIATRIC BRAIN TUMOR CHEMOTHERAPEUTIC EFFICACY Neuro-Oncology. 21: vi86-vi86 |
| Ugolkov A, Qiang W, Bondarenko G, et al. (2017) Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models. Translational Oncology. 10: 669-678 |
| Sita TL, Kouri FM, Hurley LA, et al. (2017) Dual bioluminescence and near-infrared fluorescence monitoring to evaluate spherical nucleic acid nanoconjugate activity in vivo. Proceedings of the National Academy of Sciences of the United States of America |
| Wainwright DA, Horbinski CM, Hashizume R, et al. (2017) Therapeutic Hypothesis Testing With Rodent Brain Tumor Models. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics |
| Grossauer S, Koeck K, Murphy NE, et al. (2016) Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma model. Oncotarget |
| Dasgupta T, Olow AK, Yang X, et al. (2016) Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma. Journal of Neuro-Oncology |
| Lu Y, Chang Y, Cheng L, et al. (2015) MTR-07GLIOBLASTOMA ADAPTATION TO SUSTAINED cdk4/6 INHIBITION INVOLVES SUPPRESSION OF Rb EXPRESSION THROUGH HISTONE H3K4 MODIFICATION Neuro-Oncology. 17: v125.3-v125 |
| Ugolkov A, Bondarenko G, Gaisina I, et al. (2015) ATPS-91GSK-3 INHIBITOR 9-ING-41 ENHANCES GENOTOXIC THERAPY OF GBM LEADING TO CURE FROM INTRACRANIAL BRAIN TUMOR Neuro-Oncology. 17: v38.3-v38 |